The Clinical Spectrum and Significance of ABCC8 Gene Variants in the Diagnosis of Monogenic Diabetes
Authors:
- Natalia KapelanNKNatalia Kapelan
- Piotr TustPTPiotr Tust
- Sebastian SkoczylasSSSebastian Skoczylas
- Tomasz PłoszajTPTomasz Płoszaj
- Karolina GadzalskaKGKarolina Gadzalska
- Monika GorządekMGMonika Gorządek
- Paulina JakielPJPaulina Jakiel
- Ewa JuścińskaEJEwa Juścińska
- Edyta BudzyńskaEBEdyta Budzyńska
- Maciej BorowiecMBMaciej Borowiec
- Agnieszka SzadkowskaASAgnieszka Szadkowska
- Renata StawerskaRenata Stawerska
Open Access
- 13 October 2026
- journal article
- research article
- Published by MDPI AG in Diabetology
- Vol. 7 (10) , 199
Abstract
Background: ABCC8 gene variants have been linked to a range of conditions that affect insulin secretion, such as congenital hyperinsulinism, neonatal diabetes and maturity-onset diabetes of the young (MODY). This study aimed to characterise ABCC8 variants and to assess their relationship with clinical phenotypes and family segregation. Methods: Between 2017 and May 2026, tNGS (targeted next-generation sequencing) analysis was performed on the DNA of 1202 patients who were referred for suspected monogenic diabetes. The exons and flanking intronic regions of the ABCC8 gene were assessed for single nucleotide variants (SNVs) and small insertions and deletions (indels). Rare variants were prioritised based on population frequency, in silico predictions and clinical classification. Selected variants were confirmed, and segregation analysis was performed using Sanger sequencing. Results: We identified five patients carrying pathogenic or likely pathogenic ABCC8 variants. A frameshift ABCC8 variant had not been previously reported. All patients had diabetes, with some also presenting with a history of hypoglycaemia. Family studies also revealed intra-familial variability and enabled the identification of previously unrecognized affected relatives. Conclusions: Our findings support the broad clinical spectrum associated with ABCC8 variants and highlight the importance of family segregation analysis. Comprehensive molecular and clinical evaluation may improve the detection of patients with ABCC8-related diabetes and distinguish this condition from other forms of monogenic diabetes.Keywords
This publication has 27 references indexed in Scilit:
- Search for the most precise diagnosis of monogenic diabetes - the usefulness of short-read NGS method in molecular testing in Polish patientsActa Diabetologica, 2026
- Identification of heterozygous mutations of ABCC8 gene responsible for maturity-onset diabetes of the young with exome sequencingActa Diabetologica, 2024
- Structure of an open KATP channel reveals tandem PIP2 binding sites mediating the Kir6.2 and SUR1 regulatory interfaceNature Communications, 2024
- The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinionCommunications Medicine, 2023
- Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetesDiabetes Research and Clinical Practice, 2022
- Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapyDiabetic Medicine, 2019
- Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes RegistryDiabetologia, 2016
- Congenital hyperinsulinism: Clinical and molecular analysis of a large Italian cohortGene, 2013
- Permanent Neonatal Diabetes Caused by Dominant, Recessive, or Compound Heterozygous SUR1 Mutations with Opposite Functional EffectsThe American Journal of Human Genetics, 2007
- A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1The Lancet, 2003